FDA's Gottlieb Applauds Drug Rebates At Point-Of-Sale

The US FDA commissioner called recent initiatives to get drug rebates to patients at point-of-sale "healthy" public policy, and suggested insurance premiums have been subsidized by sick patients, addressing CNBC's health care conference.

CNBC’s Meg Tirrell interviews Scott Gottlieb, M.D., Commissioner of Food and Drugs, U.S. FDA, at CNBC’s Healthy Returns conference March 28th in NYC (
CNBC's Meg Tirrell interviews Scott Gottlieb at CNBC's Healthy Returns conference • Source: David Grogan/CNBC

FDA Commissioner Scott Gottlieb applauded recent announcements by health insurers to get drug rebates into the hands of patients at the point-of-sale, while speaking at CNBC's Healthy Returns conference in New York City March 28.

Although payer issues fall outside his jurisdiction, Gottlieb's comments underscore the Trump Administration's interest in the point-of-sale rebate idea. His...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Government Payers

More from Market Access